Mitoxantrone Completed Phase 3 Trials for Neoplasms / Prostatic Neoplasms Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00417079XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer
NCT00436839Taxotere Prostate Cancer New Indication Registration Trial in China